🧬 biology

Spatial Immune Model of Alveolar Lung Infection (SIMALI) Identifies Structural Determinants of Lung Inflammation

The study introduces SIMALI, a novel 3D computational model that demonstrates how the spatial architecture of alveolar sacs and the initial distribution of viral infection critically determine the variability and progression of lung inflammation observed in SARS-CoV-2 patients.

Original authors: Humayra Tasnim, Stephanie Forrest, Steven Hofmeyr, Alan Friedman, Ronak Etemadpour, Akil Andrews, Judy Cannon, Melanie Moses, Hossein Mehdikhani

Published 2026-06-24

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Humayra Tasnim, Stephanie Forrest, Steven Hofmeyr, Alan Friedman, Ronak Etemadpour, Akil Andrews, Judy Cannon, Melanie Moses, Hossein Mehdikhani

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: Why Do Lungs Get Damaged?

When you catch a respiratory virus like the flu or SARS-CoV-2, the virus itself is bad, but the real trouble often comes from your body's own defense system. Think of your immune system like a fire department. When it sees a fire (the virus), it rushes in with water and hoses (inflammation). Sometimes, the fire department is so aggressive that it floods the house, causing more damage than the fire itself.

This paper asks a specific question: Why do some people get mild lung damage while others get severe damage, even if they have similar amounts of virus?

The authors, led by Humayra Tasnim, built a computer model called SIMALI to answer this. They wanted to see if the shape and structure of the tiny air sacs in our lungs (alveoli) play a secret role in how the infection spreads and how much damage occurs.

The Old Way vs. The New Way

The Old Model (SIMCoV):
Imagine trying to understand how a rumor spreads in a crowd by assuming everyone is standing in one giant, flat circle, all mixed together. If one person starts talking, everyone hears it instantly. Previous computer models treated the lung like this "well-mixed" soup. They assumed the virus could float freely everywhere, and the damage would spread evenly in a perfect circle.

The New Model (SIMALI):
The authors realized lungs aren't a flat circle; they are more like a bunch of grapes.

The Structure: Your lungs are made of millions of tiny air sacs (alveoli). Each sac is like a small room filled with air, lined with cells, and surrounded by thick walls (lung tissue).
The Rules: In this new model, the virus moves differently depending on where it is:
- In the Air: The virus zooms around fast (like a bird flying in an open field).
- In the Cells: The virus moves slowly (like a person walking through a crowded hallway).
- Through the Walls: The virus struggles to get through the thick tissue between sacs (like trying to push through a brick wall).

What the Computer Simulations Showed

1. The "Grape" Structure Acts as a Shield
The researchers ran simulations comparing the old "flat circle" model to their new "bunch of grapes" model.

Result: In the old model, the infection spread everywhere quickly, creating a huge, uniform ring of damage.
Result: In the new SIMALI model, the infection got stuck inside the specific "grape" (alveolar sac) where it started. The thick walls between the sacs slowed the virus down significantly.
Takeaway: The physical structure of the lung naturally limits how far the virus and the resulting inflammation can travel. It acts like a series of firewalls.

2. Where You Start Matters More Than How Much You Start With
The team tested what happens if you drop a few virus particles in different places.

Scenario A: You infect one single "grape." The damage stays small and contained.
Scenario B: You infect eight "grapes" scattered across the lung. The damage is much larger, even though the total number of virus particles was the same.
Takeaway: It's not just about how many virus particles you breathe in; it's about where they land. If they land in many different spots at once, the damage spreads much faster because the immune system has to fight fires in multiple rooms simultaneously.

3. Matching Real Patients
The researchers checked their model against real CT scans of patients with COVID-19.

The Real World: CT scans show that lung damage isn't a perfect circle. It looks like "patchy" spots or "ground glass" (foggy areas) scattered around the lung.
The Simulation: When SIMALI ran with realistic rules, it produced these exact same patchy, scattered patterns. It successfully predicted how fast the damage grew and how big it got, matching the real-life data from patients.

The "Fire Department" Analogy

To visualize the immune response in this model:

The Virus is the spark.
The Inflammation is the fire.
The Immune Cells (T-Cells) are the firefighters.

In the SIMALI model, because the "rooms" (alveoli) are separated by thick walls, the fire (inflammation) often gets trapped in the room where the spark started. The firefighters arrive, put out the fire in that specific room, and the damage is contained. However, if the spark lands in many rooms at once, the firefighters are overwhelmed, and the "fire" spreads to more of the house.

What This Means (According to the Paper)

The paper concludes that the architecture of the lung is a major reason why lung damage varies so much between people.

The "bunch of grapes" structure naturally slows down the spread of infection.
The specific location where the virus first lands determines how much of the lung gets hurt.
This model helps explain why some people have small, patchy spots of damage while others have widespread issues, even if their initial viral load seems similar.

Important Note: The authors state that this model is a tool to help us understand the mechanics of the disease. They do not claim this model can currently predict exactly what will happen to a specific patient in a hospital, but it provides a much better map of how the virus and inflammation move through the complex structure of the lung than previous models did.

Technical Summary: Spatial Immune Model of Alveolar Lung Infection (SIMALI)

Problem Statement
Respiratory viral infections, such as SARS-CoV-2, cause significant morbidity and mortality primarily through sustained lung inflammation and tissue damage rather than the viral infection itself. While computational models exist to study viral dynamics and immune responses, most rely on Ordinary Differential Equations (ODEs) that treat the lung as a "well-mixed" environment. This approach fails to capture the spatial heterogeneity of infection, the specific architecture of alveolar sacs, and the biophysical mechanisms governing lesion shape, size, and distribution. Furthermore, existing spatial models often lack the specific cellular context of the lung, such as the distinction between infectable and non-infectable cell types and the differential diffusion rates of viruses and inflammatory signals through air versus dense tissue. This gap limits the understanding of how alveolar structure influences the variation in lung damage observed across patients, including the development of post-acute sequelae (Long COVID).

Methodology
The authors propose SIMALI (Spatial Immune Model of Alveolar Lung Infection), a novel agent-based model (ABM) that explicitly represents the lung's alveolar space as a structured 3D lattice.

Structural Representation: Unlike previous models (e.g., SIMCoV) that used uniform grids of infectable cells, SIMALI models alveolar sacs as cubes (~1500µm diameter) containing a heterogeneous mix of four distinct components:
1. Air: Facilitates rapid diffusion.
2. Type I Pneumocytes: Non-infectable epithelial cells (95% of surface) responsible for gas exchange.
3. Type II Pneumocytes: Infectable epithelial cells (5% of surface) that produce surfactant and serve as progenitors.
4. Lung Tissue: The dense structural tissue surrounding sacs, which restricts diffusion.
Diffusion Dynamics: The model assigns specific diffusion coefficients based on the physical properties of each compartment. Virions and inflammatory signals diffuse rapidly through air (coefficient = 1) but are significantly restricted in lung tissue (coefficient = $1 \times 10^{-4}$ for virions, $6 \times 10^{-4}$ for inflammation). Inflammation diffuses six times faster than virions across all cell types.
Immune Response: The model incorporates an incubation phase for infected cells, followed by an expressing phase where they produce virus and inflammatory signals. Activated CD8+ T cells extravasate when inflammatory signals exceed a threshold (typically arriving at 7 Days Post-Infection, DPI), migrate randomly, and induce apoptosis in infected cells.
Validation: SIMALI predictions are validated against longitudinal Computed Tomography (CT) scans from 20 patients with mild-to-moderate SARS-CoV-2 infection. The study quantifies individual lesion volumes and calculates Lung Lesion Burden (LLB) (ratio of total lesion volume to total lung volume) to compare simulation outputs with clinical data.

Key Contributions

Structural Determinants of Inflammation: SIMALI is the first model to integrate the specific 3D architecture of alveolar sacs and the physiological percentages of infectable (Type II) vs. non-infectable (Type I) cells to study viral spread.
Differential Diffusion Mechanisms: The model introduces biologically realistic diffusion constraints, demonstrating how the physical density of lung tissue and the presence of air spaces fundamentally alter the spatiotemporal spread of infection compared to homogeneous models.
Patient-Specific Replication: The model successfully replicates the growth trajectories of specific individual lung lesions observed in patient CT scans, matching both volume and spatial expansion patterns without extensive parameter tuning.
Mechanistic Explanation for Variability: The study identifies that the initial spatial deposition of viral foci across alveolar sacs, rather than just the total viral load, is a primary determinant of the extent of lung inflammation and damage.

Results

Constrained Spread: Simulations show that the alveolar structure significantly limits the spread of virus and inflammation. Compared to a homogeneous model (SIMCoV), the structured SIMALI model reduced the volume of infected and inflamed cells by 97–99% at 6 DPI. The spread was largely contained within the initially infected sacs before T-cell arrival.
Impact of Initial Deposition: The number of alveolar sacs initially seeded with infection (Foci of Infection, FOI) directly correlates with the total volume of lung damage. While the viral load dynamics were similar across different FOI counts, the spatial extent of inflammation scaled with the number of infected sacs.
Validation against CT Data:
- Growth Rates: SIMALI simulations using biologically plausible default parameters (1% initial infection of infectable cells) accurately reproduced the median patient inflammation growth rate, which peaked sharply around 2 DPI and declined by 7–10 DPI.
- Lesion Burden: The model captured the rapid rise and subsequent plateau of Lung Lesion Burden (LLB), reflecting sustained tissue damage even after viral clearance.
- Individual Lesions: A specific lesion from Patient 706 (growing from 0.7 cm³ to 1.2 cm³ between 2 and 8 DPI) was successfully replicated in SIMALI, confirming the model's ability to simulate patient-specific lesion trajectories.
Sensitivity Analysis: The model is highly sensitive to viral infectivity and virion production rates, which drive inflammation growth and LLB. Lung tissue diffusion plays a secondary but significant role; reduced diffusion limits spatial spread but can paradoxically elevate local inflammation growth rates due to inefficient immune signaling.

Significance and Claims
The paper claims that SIMALI provides a critical "spatial lens" to complement existing ODE models, offering a mechanistic explanation for the patchy, heterogeneous nature of lung lesions observed in CT scans (e.g., Ground Glass Opacities). The authors assert that the spatial architecture of alveolar sacs acts as a natural constraint on viral and inflammatory spread.

The study concludes that the high variability in lung damage observed across patients is driven by a combination of:

The specific structural organization of the alveolar space.
The initial location and distribution of viral deposition.
Variation in immune response parameters (infectivity, production rates).

By accurately reproducing patient-specific lesion growth and population-level trends, SIMALI is presented as a potential predictive tool for assessing individual patient outcomes and understanding the mechanisms leading to persistent lung damage and post-acute sequelae. The authors note that while the current model simulates a small volume (~0.7 cm³) compared to a full lung, it establishes the foundational principles for how alveolar structure dictates infection dynamics.